Ace the Oncology Nursing Game: 2026 Chemo-Bio Certification Practice Test Adventure!

The symptom that would most likely indicate the nadir phase in a chemotherapy patient is a low white blood cell count. The nadir represents the period of lowest blood cell counts following chemotherapy treatment, particularly affecting the bone marrow's ability to produce blood cells. During this time, patients are at an increased risk for infections, bleeding, and anemia due to the depletion of neutrophils, lymphocytes, and other blood components.

Monitoring white blood cell counts during chemotherapy is crucial for patient safety, as it helps in anticipating complications and managing supportive care. Patients often experience severe neutropenia, which is a significant drop in white blood cells, making them more susceptible to infections during the nadir period. This assessment is a fundamental component of chemotherapy management and helps guide clinicians in timing subsequent doses of chemotherapy or implementing protective measures against infections.

In contrast, symptoms such as an elevated heart rate may indicate other issues, such as dehydration or anxiety, while increased energy levels and improved mood are typically not associated with the nadir phase, as patients usually feel more fatigued and vulnerable during this time.